Skip to main content
OLMA logo

OLMA · Olema Oncology, Inc. · Executive Compensation

Track OLMA — free
$7.02 -0.13 (-1.82%) At close · Nov 20 Play latest call Q4 2024 earnings call transcript
Market Cap
$615.00M
Shares
87.61M
Volume · Nov 20 1.26M Avg daily vol (3M) 1.27M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Dr. Prakash Raman Appointed 2026-10-15
Dr. Gorjan Hrustanovic
“Dr. Hrustanovic’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
Resigned 2026-10-15
Jason O'Byrne Appointed 2026-08-13
Jason O'Byrne Appointed 2026-08-13
Jason O'Byrne Appointed 2026-08-13
Dr. Prakash Raman Appointed 2026-04-29
Yi Larson Appointed 2021-04-06
Frank McCormick
“Dr. McCormick’s resignation was not the result of any disagreement or dispute with the Company.”
Resigned 2021-04-06

Leadership

Key facts CIK 1750284 CUSIP 68062P106 13F (30d) 188 filings 170 filers Visit website Investor relations